Cristcot LLC   Report issue

For profit Phase 1 Phase 3
Founded: Concord MA United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2016
NCT02671058
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Cristcot HCA LLC | Cristcot LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

hydrocortisone (solu-cortef) (1 trial)

Drugs in Phase 1 Trials (1)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Proctitis (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2